Phoenix, AZ - (NewMediaWire) - March 12, 2019 - For The Earth Corporation (the “Company” or “FTEG”) (OTCMKTS: FTEG) issues the following Letter to Shareholders from the CEO:Dear Valued Shareholder,As our recent communications have outlined, we are transitioning into a vertically integrated CBD producer and retailer. We are extremely grateful to our committed shareholders for joining us on this exciting journey. Today, I wanted to bring you up to date on what we have accomplished and what our next steps will be.First off, our new website is up and live. You can find it at ftegco.com. Be sure to check back often to follow our progress there.Next, I am very excited to announce that we are making strong progress on acquiring our new state-of-the-art CBD extraction and production facility. We have sharply narrowed down our list of top candidates with the goal of closing on a facility by next month. This is an enormously important piece of the puzzle for setting our fully integrated vision in motion. We will be outfitting the facility with a high-capacity supercritical CO2 extraction machine along with other essential equipment and moving quickly into production.I am also very excited to report that we will be launching our own distribution facility in Phoenix, AZ. That facility should be fully up and running by April 2 – and possibly sooner than that. This will be our distribution hub and will serve as a primary sourcing point for all of our major end markets, including full-spectrum high-potency CBD products, a range of pet products, and our Bacteria Elimination cleaning products.With our new emphasis on the rapidly growing CBD market, it’s easy to forget that we have tremendous traction in the hi-tech cleaning products marketplace. Our Clean Life brand uses advanced Nano-mechanics to destroy pathogens and leave a protective shield (our “Advanced Coating Technology”) on surfaces to inhibit the growth of new pathogens where treatment with Clean Life products has occurred – all without the use of harsh or harmful chemicals.If you want to understand more about our cleaning products, our technology, or the science behind this process, please visit our Clean Life products site at cleanlifecorp.com.Finally, I wanted to update our recent moves to expand our CBD retail footprint. We will be interfacing with end-market consumers in a range of ways, as we have noted in recent communications. Two of the most powerful avenues are our CBD mall kiosks and CBD vending machines.Our mall kiosk strategy will focus on both human CBD products and pet products, including CBD for pets, which is a surprisingly powerful growth market. It shouldn’t be surprising if you take a moment to think about it. CBD is an extremely effective agent on so many fronts for animal physiology given its interaction with the endocannabinoid system. Those same CB1 and CB2 receptors that have such an impact on our own physiology are present in our furry friends as well. And most pet owners desire natural, organic products that increase the well-being of their pets.To give you a sense of how big this market could become, pet owners spent over $30B in 2016 on pet supplies, treatments, and veterinary care, according to the American Pet Products Association. Some percentage of that spending is a substitution target for CBD products.Our first kiosk will focus on human CBD products. Our second will focus on the pet market.In addition, our Las Vegas retail footprint will be open and active beginning next week. We also plan to expand aggressively into the Arizona and Florida markets next.Best Regards,Nelson Grist, CEOAbout For The Earth CorporationFor The Earth Corporation is an emerging integrated CBD producer and retailer in the United States. The Company is in the process of establishing a vertical framework that will extend from cultivation to extraction and production to a strategic retail footprint that includes multiple locations in Las Vegas and New York featuring mall kiosks, vending machines, e-commerce, and full store locations serving both the human and pet CBD ...
Seattle, WA - (NewMediaWire) - March 12, 2019 - CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an article discussing FluroTech Ltd. (TSX-V: TEST) (OTCQB: FLURF). The company recently announced a new proof-of-concept for its advanced cannabis biomarker technology, which enables cultivators, dispensaries, and regulators to easily trace products across the supply chain.The cannabis industry is projected to exceed $146 billion by 2025, according to Grand View Research, driven by the legalization of adult-use and medical cannabis around the world. With the breakneck pace, the industry has faced a number of growing pains along the way. Product recalls, counterfeit products, mislabeled products, and supply chain issues have introduced challenges for growers, dispensaries, consumers, and regulators.Supply Chain ChallengesThe cannabis industry has experienced rapid growth over the past several years, but there have been plenty of growing pains along the way. According to one study, 35 percent of more than 80 cultivars tested had genetics that didn’t match the cultivar being sold. Consumers were buying Sativa cultivars that were advertised as Indica and vice versa. California cannabis labs are also finding toxic metals in vape cartridges, which could cause serious health issues.Counterfeit products have caused other problems. G Pen, a leading high-end portable vaporizer, was awarded $47 million in 2017 after suing more than 60 online retailers selling counterfeit versions of their products. Even worse, some dispensaries were found to be selling fake vape cartridges, which could introduce health risks since the contents of those cartridges are completely unknown and unregulated.“Legal cannabis markets around the world continue to express concern about black market production entering regulated systems,” says FluroTech CEO Danny Dalla-Longa. “Regulators, responsible for consumer protection, have noted an increase in the number of these allegations. Legal growers need to protect their brands and reputation, which we believe creates an expanding market for our technology.”Governments have also struggled to control the supply chain. Without a good way to track legal product, there’s no way for them to ensure that legal cannabis remains out of the black market and black market cannabis remains out of the legal market. Tracking solutions could also enable them to trace cannabis back to its origins for tax collection purposes, as well as to assist with any product recalls that may be issued.Please Click Here to Receive a FluroTech Investor Presentation and Future Updates.Biomarker-based SolutionsDNA biomarkers, short for biological markers, have become a popular way to track everything from clothing to livestock. After applying a spray solution, the DNA acts as a molecule-sized encrypted barcode that can be used to track almost anything across a supply chain. The fashion industry, for example, has used the technology to verify the authenticity of high-end clothing and accessories to combat counterfeit products.The same technology can be applied to the cannabis industry. By bonding to the plant, biomarker technologies can withstand processing and even show up in refined products, such as oils and edibles. Dispensaries, regulators, cultivators and other interested parties can feed the product into a reader to access the unique “encrypted barcode”. This information can be used to confirm the origin, strain, permit or other relevant information.While most conventional biomarking technologies utilize sprays, FluroTech’s CTO Dr. Elmar Prenner doesn’t believe that these will be acceptable under future Health Canada regulations. The company recently announced a proof-of-concept technique that introduces water-based biomarkers through the root system of cannabis and hemp plants, so that the nanoparticles are absorbed throughout all of the plant.Using the company’s cost-effective CompleTest™ equipped with biomarking scopes, these unique ...
Coconut Creek, FL - (NewMediaWire) - March 12, 2019 - NutraLife Biosciences, Inc. (“the Company” or “NutraLife”) (OTCQB: NLBS) announces it has signed an agreement with Orlando Pharmacy, a USP 797 compliant compounding pharmacy, to provide its technologies and an innovative delivery system for pharmaceutical products.Craig Sicinski, a pharmacist and owner of Orlando Pharmacy and a board advisor to BioHealth Technologies, a CBD and nutraceutical AI PAAS (Platform As A Service) company, commented, “We are thrilled to have this new agreement with NutraLife and to use its technologies and delivery system in our pharmaceutical products. Our shared goal is to discover new innovations within the life sciences space.”Edgar Ward, CEO and Founder of NutraLife Biosciences, stated, “This is a great opportunity for us to expand our technologies and delivery systems into the Pharmaceutical marketplace. Pharmacist Craig Sicinski of Orlando Pharmacy is in-line with our mission to develop the most effective and efficient delivery systems. With Orlando Pharmacy, we are taking our first steps into the pharmaceutical marketplace.”“We are excited to explore the possibilities for our technologies and processes in the life sciences space and to have our technologies and delivery systems used in the creation of compounded pharmaceutical products by the pharmacists at Orlando Pharmacy, an experienced cGMP facility. We look forward to a long and rewarding relationship with Mr. Sicinski and his team at Orlando Pharmacy,” said Mr. Ward.Orlando Pharmacy is a USP 797 compliant pharmacy that has been serving the Orlando community for more than 60 years. Orlando Pharmacy is designated as a Good Neighbor Pharmacy, a network of more than 4,5000 independent pharmacies. Orlando Pharmacy prides themselves on their reputation for credibility, integrity, and always going the extra mile to meet the needs of its customers and patients.”NutraLife Biosciences, Inc. operates a multifaceted life sciences company. Since 2013, NutraLife's manufacturing facility has been registered with the FDA and operated in accordance with the GMP standard. The Company manufactures and distributes private label and branded nutraceutical and wellness products. Through its subsidiaries, Precision Analytic Testing, Inc., and PhytoChem Technologies, Inc., the Company provides bulk material analytical, identity, potency and purity testing of raw hemp, hemp cultivation, raw bulk material extraction and processing. In February of 2019, the Company's subsidiary, NutraDerma Technologies, Inc. acquired its first product, a patented all natural dermal patch designed to ward off insects including mosquitoes.NutraLife Sciences is a fully reporting company with a class of securities registered with the U.S. Securities and Exchange Commission (“SEC”). NLBS recently announced its financial results for the three (3) and nine (9) month period ended September 30, 2018 with revenue of $1,062,146 and $2,870,462 respectively compared to $652,385 and $1,027,727 for the three (3) and nine (9) month period ended September 30, 2017. NLBS’s filings with the SEC can be viewed at www.sec.gov. NLBS’s CBD products and information about the company’s direct sales program can be found online at https://nutrahempcbd.com and by following the company on Instagram.* These statements have not been evaluated by the Food and Drug Administration.* This product is not intended to diagnose, treat, cure or prevent any disease.Forward-Looking StatementsThis communication from NutraLife BioSciences, Inc. (the “Company”) contains statements of a forward-looking nature. These statements are made under the “safe harbor” provisions of the U.S. Private Securities Litigation Reform Act of 1995. You can identify these forward-looking statements by words or phrases such as “may,” “will,” “except,” “anticipate,” “aim,” “estimate,” “intend,” “plan,” “believe,” “is/are likely to,” “future” or other similar expressions. The Company has based these forward-looking statements largely on the Company’s current expectations and ...
Annual Product Revenues Up 54%SOUTH ORANGE, NJ - (NewMediaWire) - March 12, 2019 - Nephros, Inc. (OTCQB:NEPH), a commercial stage company that develops and sells high performance liquid purification filters for both medical device and commercial markets, today announced financial results for the three months and full year ended December 31, 2018.Fourth Quarter Financial HighlightsProduct revenue was $1.6 million, up 33% compared to $1.2 million in 2017.Total revenue was $1.6 million, up 24% compared to $1.3 million in 2017.Net loss in the Water Filtration business segment was $272,000, compared to net income of $1,316,000 in 2017.Adjusted EBITDA in the Water Filtration business segment was $136,000, compared to ($71,000) in 2017.Year-End 2018 Financial HighlightsProduct revenue was $5.5 million, up 54% compared to $3.5 million in 2017.Total revenue was $5.7 million, up 50% compared to $3.8 million in 2017.Net loss in the Water Filtration business segment was $2,416,000, compared to net loss of $766,000 in 2017.Adjusted EBITDA in the Water Filtration business segment was ($861,000), compared to ($1,247,000) in 2017.Full Year 2019 Financial GuidanceRevenues of $8.5 to $9.5 million, an increase of 50% to 65% over 2018.Continued gross margins 55% to 60%.Positive Adjusted EBITDA in the Water Filtration business segment.Daron Evans, President and CEO of Nephros stated, “We are very pleased with our 2018 performance, including the continued momentum in our Water Filtration business segment, which met our plan to grow at least 50% and which delivered positive Adjusted EBITDA in the fourth quarter. In addition, at the end of 2018, we expanded our business with the acquisition of Biocon 1, LLC and its Aether brand of water filtration systems. We expect this acquisition to accelerate our overall growth and to expedite our entry into the food service, hospitality, and convenience store markets.”Corporate UpdateHospital Infection Control MarketIn 2018, revenue from the hospital infection control market grew approximately 57% from 2017, driven primarily by increased sales through our strategic distribution partners. We continue to focus on water safety education and patient safety. We moved into our new offices near the Newark airport to assist in launching our “same day” service – routinely shipping orders to customers all over the country in their time of need.“We appreciate the efforts our customers and strategic partners have undertaken over the last few years to increase awareness of waterborne pathogens, and to develop proactive management strategies to reduce the risk of patient infection,” said Shane Sullivan, Vice President of Sales. “We have seen the whole industry increase the number of proactive measures taken to prevent infection from waterborne pathogens. We are proud to provide a suite of products that complement other technologies in a multibarrier approach to infection prevention.”Commercial / Industrial Water Filter MarketAt the end of 2018, we acquired Biocon 1, LLC and Aether Water Systems, LLC (together, “Aether”). The Aether product portfolio includes water filters that improve the taste and odor of water and reduce scale build-up in downstream equipment. Aether products target the food service, hospitality, and convenience store markets. We expect the Aether acquisition to provide accretive growth and have an immediate positive impact on revenues. Additionally, we expect Aether to expedite our entry into multiple large market segments. We believe that enabling Aether to fully leverage our sales, marketing, engineering, and quality infrastructure will enable Aether’s revenue to grow more quickly.“With the additional scale and engineering acumen of Nephros, we believe we will be better able to pursue national accounts and expand our manufacturing capabilities,” said Greg Lucas, President of Aether. “For many years, our products have been performing well in the market and we look forward to accelerating our commercial expansion.”Dialysis Water Filter MarketRevenue from the dialysis water filter market grew by ...
Opportunity to collaborate with industry experts in the biomass conversion to high value product marketMILTON, GA - (NewMediaWire) - March 12, 2019 - Attis Industries Inc. (NASDAQ: ATIS) (the “Company” or “Attis”), a diversified innovation and technology holding company, announced that it will be attending and presenting at the Biorenewable Deployment Consortium (“BDC”) today in Jacksonville, FL.This will be the fourth time that Attis has attended the BDC and the third time as a presenter. Attis is looking forward to providing an update on its various projects and technologies to a very well attended conference that focuses primarily on the valorization of biomass across multiple markets. Attis plans to provide an update on its recently announced planned acquisition of the Sunoco LP corn ethanol plant in Fulton, NY as well as its biorefinery project in Barnesville, GA. The BDC is the perfect opportunity for Attis to discuss its suite of biomass conversion technologies, specific project updates and end product market development. Year after year, the BDC continues to draw some of the industry’s most influential minds with regards to the valorization of biomass and its various constituents. Attis welcomes the opportunity to collaborate with industry experts and looks forward to receiving input and new perspectives from the attendees.“We are always eager to participate in conferences like the Biorenewable Deployment Consortium,” stated Jeff Cosman, Attis Industries CEO. “Conferences like the BDC are a fantastic opportunity to partake in discussions that directly impact one of Attis’ core business segments. The conference format and level of competency of its attendees presents a great chance for Attis to gather alternative perspectives and network with numerous potential customers and partners.”Presenting at the conference will be Attis’ VP of Marketing, Chris Kennedy. Mr. Kennedy is a 15-year veteran of the renewable fuels industry and works closely with senior management on the development of Attis’ various biorefinery projects and end product market development.Attis Industries, Inc. Attis Industries Inc. (NASDAQ: ATIS) is a diversified innovation and technology holding company focused on developing and building businesses that play important roles in the new economy. We strive to encourage our employees to be entrepreneurs focused on innovation and technology. We will remain dynamic, persistent and motivated to our mission of winning. The growth of our company will rely on our integrity and our vision for the future. Today, each of Attis business sectors provide high growth opportunities that collectively account for more than a third of our nation’s GDP. For more information, visit: www.attisind.comForward-Looking StatementsAny statements contained in this press release that do not describe historical facts may constitute forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. You can identify forward-looking statements by words such as “anticipate,” “believe,” “could,” “estimate,” “expect,” “intend,” “may,” “plan,” “should,” “would” or similar words. You should consider these statements carefully because they discuss our plans, targets, strategies, prospects and expectations concerning our business, operating results, financial condition and other similar matters. These statements are subject to certain risks, uncertainties, and assumptions, including, but not limited to, risks and uncertainties relating to the Company's ability to develop, market and sell products based on its technology; the expected benefits and efficacy of the Company's products and technology; the availability of substantial additional funding for the Company to continue its operations and to conduct research and development, clinical studies and future product commercialization; and, the Company's business, research, product development, regulatory approval, marketing and distribution plans and strategies; the ability of the Company to continue to meet the listing requirements ...
Las Vegas, NV - (NewMediaWire) - March 12, 2019 - Meso Numismatics, Inc. (“Meso Numismatics” or the “Company”) (OTC: MSSV), a technology and numismatic company specializing in the Meso Region, including Central America and the Caribbean, announced that last week, the Company has formally submitted the OTCQB application materials to OTC Markets Group, operator of OTCMarkets.com. Melvin Pereira, President of Meso Numismatics, Inc., stated, “Last Thursday, March 7th, we submitted the OTCQB application materials to be reviewed by the OTC Markets Group, to upgrade the Company to the OTCQB. We expect this application to be approved, and if it is, the Company will trade on a more transparent stock marketplace. This is in addition to making the appropriate filings with the SEC.”The Company already maintains a Verified Company Profile at OTCMarkets.com.While the Company’s application for the OTCQB is pending review, management, with the assistance of its outside counsel, will continue working closely with the OTC Markets Group, to supply any additional information needed for the upgrade. Management will continue to keep shareholders informed of the progress once the Company receives further information from the OTC Markets Group. Upgrading to the OTCQB is expected to improve the Company’s position in the public markets and increase visibility to the investment community.For more information about Meso Numismatics, please visit www.MesoNumismatics.com.About Meso Numismatics, Inc.Meso Numismatics is a numismatic company specializing in the Meso Region, including Central America and the Caribbean. The Company has become the main hub for rare, exquisite, and valuable inventory, not only from the Meso Region but also from around the world. Meso is the only Company in the Central American-Caribbean region that is an on-the-ground registered dealer with the Numismatic Guaranty Company (NGC) and the Paper Money Guaranty (PMG).Meso Numismatics not only boasts an impressive selection of rare inventory, but the Company also has a specialized App for banknote recognition, available on Google Play and the Apple App Store.Meso Numismatics continues its partnership with eBay (https://www.ebay.com/str/mesonumismatics). The Company continues to partner with some of the largest auction houses in the world for the sale of the Company’s rarer inventory.To view the Award-Winning PMG Set of Meso Numismatics, please visit www.mesopmgset.com.For more information, please visit www.MesoNumismatics.com or call (800) 889-9509 for personalized customer service.Forward Looking Statements: Any statements that are not historical facts and that express, or involve discussions as to, expectations, beliefs, plans, objectives, assumptions or future events or performance (often, but not always, indicated through the use of words or phrases such as "will likely result," "are expected to," "will continue," "is anticipated," "estimated," "intends," "plans," "believes" and "projects") may be forward-looking and may involve estimates and uncertainties which could cause actual results to differ materially from those expressed in the forward-looking statements. We caution that the factors described herein could cause actual results to differ materially from those expressed in any forward-looking statements we make and that investors should not place undue reliance on any such forward-looking statements. Further, any forward-looking statement speaks only as of the date on which such statement is made, and we undertake no obligation to update any forward-looking statement to reflect events or circumstances after the date on which such statement is made or to reflect the occurrence of anticipated or unanticipated events or circumstances. New factors emerge from time to time, and it is not possible for us to predict all of such factors. Further, we cannot assess the impact of each such factor on our results of operations or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking ...
